tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MedPlus Subsidiary Faces Drug License Suspensions in Karnataka

Story Highlights
MedPlus Subsidiary Faces Drug License Suspensions in Karnataka

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) just unveiled an announcement.

MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received suspension orders for drug licenses at two store locations in Karnataka. The suspensions, issued by the Drugs Control Administration, are expected to result in a potential revenue loss of approximately Rs 2.83 lacs. This development may impact the company’s financial operations and highlights regulatory challenges in maintaining compliance with drug and cosmetic regulations.

More about MedPlus Health Services Ltd.

MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on retail pharmacy services. The company is known for its extensive network of pharmacy stores across India, providing a range of pharmaceutical products and health-related services to consumers.

Average Trading Volume: 21,181

Technical Sentiment Signal: Sell

Current Market Cap: 91.72B INR

Learn more about MEDPLUS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1